It's obvious that the company has a good shot at returning to growth.

The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.

U.S.-based biotech stocks are closely watching the China's rapid advance into the biotech field. Will they withstand the ...

There's a growth stock that has skyrocketed more than Google parent Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) and Nvidia ...

Artificial intelligence (AI) isn't the only industry with explosive growth potential.

Healthcare stocks rebounded in 2025. These three healthcare growth stocks offer exposure to innovation beyond traditional ...

Swiss-American biotechnology company, CRISPR Therapeutics AG (NASDAQ: CRSP), has come under renewed pressure in recent weeks, ...

But deciding if it's a good buy takes a little more looking.

CalciMedica had been evaluating the therapy, called Auxora, in the Kourage trial of patients with stage 2 or 3 AKI with ...